SQUAWK/NEWS
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

2 results loaded, newest first. End of these results.

News 2026-06-29 16:59 UTC

AstraZeneca Advances Rare Bone Disease Pipeline While Enhertu Expands In Europe

On Sunday, AstraZeneca Plc (NYSE: AZN ) reported positive late-stage data for investigational therapy efzimfotase alfa in children with hypophosphatasia (HPP), while separately securing European Union approval for cancer drug Enhertu in a broad group of HER2-positive solid tumors, marking two significant milestones acr